|
Mouse model of infant acute megakaryocytic leukemia
|
5K08CA111399-04
|
$134,379
|
$134,379
|
Raffel, Glen
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
5R21CA119142-02
|
$152,926
|
$152,926
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
7R01CA113969-04
|
$316,480
|
$79,120
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
5R01CA119162-02
|
$648,827
|
$648,827
|
Drotar, Dennis
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Nucleophosmin in Fanconi's Anemia-evolved Leukemia
|
5R01CA109641-05
|
$289,623
|
$57,925
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Molecular Studies of Down Syndrome Leukemia
|
5R01CA111778-04
|
$231,698
|
$231,698
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-04
|
$255,452
|
$255,452
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES
|
5K08CA104882-05
|
$138,672
|
$138,672
|
BROWN, VALERIE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-04
|
$311,617
|
$105,950
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
5R01CA116660-02
|
$289,644
|
$289,644
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Ethnic Differences in Survival after Childhood ALL
|
5R01CA096670-05
|
$488,086
|
$488,086
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
$70,274
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
$2,854
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$3,222
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Minority Predoctoral Fellowship Program
|
5F31CA117055-04
|
$25,672
|
$12,836
|
ORTIZ, SERINA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Roles and Regulation of p53
|
5P01CA087497-08
|
$1,594,789
|
$79,739
|
Prives, Carol
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Cancer Center Support Grant
|
2P30CA013696-35
|
$3,785,244
|
$75,705
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The role of AKT signaling in NOTCH1 induced leukemias
|
1R01CA129382-01A1
|
$340,819
|
$170,410
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mechanisms of T-Cell Leukemogenesis Induced by Notch1
|
5R01CA120196-02
|
$305,900
|
$152,950
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
2P01CA066996-11A1
|
$2,299,041
|
$137,942
|
GILLILAND, D
|
DANA-FARBER CANCER INSTITUTE
|
|
Zebrafish Chemical and Classical Genetics Approach to the Pathogenesis of T-ALL
|
1K08CA133103-01
|
$140,940
|
$140,940
|
Gutierrez, Alejandro
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Pathways to Thymic Lymphoma and Leukemia
|
5P01CA109901-05
|
$1,974,630
|
$987,315
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Leukemogenic Slug Pathway in Hematopoietic Cell Survival
|
5R01CA059571-15
|
$405,347
|
$405,347
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA032291-27
|
$348,584
|
$6,972
|
WINER, ERIC
|
DANA-FARBER CANCER INSTITUTE
|
|
Deficits in Facial Expression Recognition in Childhood Cancer Survivors
|
5R03CA128472-02
|
$81,885
|
$40,943
|
BONNER, MELANIE
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA047577-21
|
$166,705
|
$3,334
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-29
|
$5,067,063
|
$101,341
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
TRICCS: Targeting Inattention in Childhood Cancer Survivors
|
5R03CA132570-02
|
$78,000
|
$39,000
|
Hardy, Kristina K.
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S1
|
$40,000
|
$800
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S2
|
|
$0
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S3
|
$249,999
|
$5,000
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S4
|
$85,106
|
$1,702
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S5
|
$100,000
|
$2,000
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-34
|
$6,558,287
|
$131,166
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Mechanisms of Leukemogenic Transformation by MLL-CALM
|
5R01CA109281-05
|
$262,921
|
$262,921
|
WECHSLER, DANIEL
|
DUKE UNIVERSITY
|
|
Functions of E2A in B Lymphocyte Development
|
5R01CA072433-11
|
$310,291
|
$155,146
|
Zhuang, Yuan
|
DUKE UNIVERSITY
|
|
MDM2 regulates XIAP gene expression in cancer treatment
|
1R01CA123490-01A2
|
$256,678
|
$64,170
|
ZHOU, MUXIANG
|
EMORY UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-38
|
$793,241
|
$95,189
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-30
|
$237,038
|
$35,556
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology and Prognostic implications of Flt3 mutations in AML
|
5R01CA114563-04
|
$422,916
|
$211,458
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer and Leukemia Group B
|
5U10CA077597-11
|
$121,638
|
$2,433
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
RBC_Encapsulated Asparaginase for Enhanced Acute Lymphoblastic Leukemia Therapy
|
1R43CA135969-01
|
$124,083
|
$62,042
|
David, Allan
|
INDUSTRIAL SCIENCE & TECHNOLOGY NETWORK
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-08
|
$546,364
|
$546,364
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing FLT3-Targeted Therapy for Pediatric Leukemia
|
5K23CA111728-03
|
$140,130
|
$70,065
|
BROWN, PATRICK
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Childhood Leukemia for this search: $48,267,255
|